Business Context and Reporting Period
This Form 8-K is a current report filed by BioSig Technologies, Inc. (not Streamex Corp.) on February 19, 2020. The registrant is incorporated in Delaware and its common stock trades on the NASDAQ Capital Market under the symbol BSGM. The report addresses a specific operational milestone rather than a standard financial reporting period.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is an event-driven report and does not contain financial statements or quantitative financial data.
Material Changes
The material event reported is the completion of 100 patient cases using the Company's PURE EP™ System. This milestone was announced via a press release filed as Exhibit 99.1.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future financial performance, or a discussion of risks and contingencies beyond the reference to the press release. No unusual items were disclosed in the text of this report.
Investor Verification Checklist
- Verify the discrepancy between the requested company name (Streamex Corp.) and the actual registrant (BioSig Technologies, Inc.).
- Review the attached press release (Exhibit 99.1) for details on the clinical significance of the 100 patient cases.
- Confirm the current status of the PURE EP™ System regulatory approval process.
- Check subsequent filings for any financial impact resulting from this operational milestone.